The wire › SEC Form 8-K
LAVA Therapeutics NV LVTX
Filed with the SEC on Feb 25, 2025. Reported event date Feb 20, 2025.
- Business address
- Utrecht, P7
- State
- Outside the U.S. or not given
- Incorporated in
- Outside the U.S. or not given
- Industry
- Manufacturing (SIC 2834)
- SEC CIK
- 1840748
- Accession number
- 0001104659-25-016712
Items reported in this filing
- Item 2.05 Costs Associated with Exit or Disposal Activities
The company reported a restructuring: it committed to exit or dispose of part of its business (for example closing some sites, ending a product line or cutting staff) and expects material costs, under Form 8-K Item 2.05. It does not mean the company is closing; healthy, profitable companies file it too, often alongside an earnings release.
- Item 7.01 Regulation FD Disclosure
- Item 9.01 Financial Statements and Exhibits
Other entries on the wire for this company
-
LAVA Therapeutics NV LVTX
-
LAVA Therapeutics NV LVTX
-
LAVA Therapeutics NV LVTX
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing